BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Diagnosis
16 results:

  • 1. Serine/threonine-protein kinase D2-mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression.
    Liu YQ; Xu YW; Zheng ZT; Li D; Hong CQ; Dai HQ; Wang JH; Chu LY; Liao LD; Zou HY; Li EM; Xie JJ; Fang WK
    J Pathol; 2024 May; 263(1):99-112. PubMed ID: 38411280
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual src and MEK1/2 inhibition.
    Rose MM; Nassar KW; Sharma V; Schweppe RE
    Med Oncol; 2023 Sep; 40(10):299. PubMed ID: 37713162
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. src heterodimerically activates Lyn or Fyn to serve as targets for the diagnosis and treatment of esophageal squamous cell carcinoma.
    Zhang J; Zhao D; Zhang L; Xiao Y; Wu Q; Wang Y; Chen J; Zhan Q
    Sci China Life Sci; 2023 Jun; 66(6):1245-1263. PubMed ID: 36763244
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Search for New Target Genes of MicroRNA for Differential diagnosis of Benign and Malignant Neoplasms of the Thyroid Gland by In Silico Methods.
    Kononchuk VV; Kopeikina EV; Kalinina TS; Saik OV; Alekseenok EY; Kolyagina MK; Matashova VA; Shevchenko SP; Gulyaeva LF; Kushlinskii NE
    Bull Exp Biol Med; 2022 Jun; 173(2):246-251. PubMed ID: 35737153
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MRI-based texture analysis to differentiate the most common parotid tumours.
    Sarioglu O; Sarioglu FC; Akdogan AI; Kucuk U; Arslan IB; Cukurova I; Pekcevik Y
    Clin Radiol; 2020 Nov; 75(11):877.e15-877.e23. PubMed ID: 32703544
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Zinc Gluconate Induces Potentially cancer Chemopreventive Activity in Barrett's Esophagus: A Phase 1 Pilot Study.
    Valenzano MC; Rybakovsky E; Chen V; Leroy K; Lander J; Richardson E; Yalamanchili S; McShane S; Mathew A; Mayilvaganan B; Connor L; Urbas R; Huntington W; Corcoran A; Trembeth S; McDonnell E; Wong P; Newman G; Mercogliano G; Zitin M; Etemad B; Thornton J; Daum G; Raines J; Kossenkov A; Fong LY; Mullin JM
    Dig Dis Sci; 2021 Apr; 66(4):1195-1211. PubMed ID: 32415564
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Gene expression differences between thyroid carcinoma, thyroid adenoma and normal thyroid tissue.
    Wang Q; Shen Y; Ye B; Hu H; Fan C; Wang T; Zheng Y; Lv J; Ma Y; Xiang M
    Oncol Rep; 2018 Dec; 40(6):3359-3369. PubMed ID: 30272326
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma.
    Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
    Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CCR7 regulates cell migration and invasion through JAK2/STAT3 in metastatic squamous cell carcinoma of the head and neck.
    Liu FY; Safdar J; Li ZN; Fang QG; Zhang X; Xu ZF; Sun CF
    Biomed Res Int; 2014; 2014():415375. PubMed ID: 25405202
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.
    Su CM; Su YH; Chiu CF; Chang YW; Hong CC; Yu YH; Ho YS; Wu CH; Yen CS; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S767-75. PubMed ID: 25212831
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Signet ring cell adenocarcinomas: different clinical-pathological characteristics of oesophageal and gastric locations.
    Piessen G; Messager M; Lefevre JH; Goéré D; Mabrut JY; Meunier B; Brigand C; Hamy A; Glehen O; Mariette C;
    Eur J Surg Oncol; 2014 Dec; 40(12):1746-55. PubMed ID: 25012732
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Protein marker profiling in different T classification in laryngeal squamous cell carcinoma.
    Chen W; Ye F; Cui M; Sikora AG; Wang X; Wang P; Cui X; Guo X; Zhu W; Zhang DY
    Head Neck; 2015 Mar; 37(3):357-65. PubMed ID: 24753215
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.
    Wu Z; Doondeea JB; Gholami AM; Janning MC; Lemeer S; Kramer K; Eccles SA; Gollin SM; Grenman R; Walch A; Feller SM; Kuster B
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.011635. PubMed ID: 21955398
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).
    Kikkawa N; Hanazawa T; Fujimura L; Nohata N; Suzuki H; Chazono H; Sakurai D; Horiguchi S; Okamoto Y; Seki N
    Br J Cancer; 2010 Sep; 103(6):877-84. PubMed ID: 20700123
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Salivary analysis of oral cancer biomarkers.
    Shpitzer T; Hamzany Y; Bahar G; Feinmesser R; Savulescu D; Borovoi I; Gavish M; Nagler RM
    Br J Cancer; 2009 Oct; 101(7):1194-8. PubMed ID: 19789535
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Molecular alterations in Barrett's esophagus and adenocarcinoma].
    Ozawa S; Ando N; Kitagawa Y; Ueda M; Kitajima M
    Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):235-9. PubMed ID: 10379532
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.